Tocilizumab-Induced Sweet Syndrome in a Familial Mediterranean Fever Patient: A Case Report
Keywords:
sweet syndrome, tocilizumabReferences
Shaikh MB, Krunic AL. Drug-Induced Sweet Syndrome. J Allergy Clin Immunol Pract. 2019;7(7):2400-2401. doi:10.1016/j.jaip.2019.07.002
Takano Y, Fujino H, Yachie A, Sumimoto SI. Serum cytokine profile in pediatric Sweet's syndrome: a case report. J Med Case Rep. 2017;11(1):178. Published 2017 Jul 2. doi:10.1186/s13256-017-1317-0
Cook QS, Zdanski CJ, Burkhart CN, Googe PB, Thompson P, Wu EY. Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review. Curr Allergy Asthma Rep. 2019;19(6):32. Published 2019 May 14. doi:10.1007/s11882-019-0864-4
Hwang S, Son H, Moon J, et al. Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil. Encephalitis. 2021;1(1):20-24. doi:10.47936/encephalitis.2020.00059
Haber R, Dib N, El Gemayel M, Makhlouf M. Paradoxical neutrophilic dermatosis induced by biologics and immunosuppressive drugs: A systematic review. J Am Acad Dermatol. 2021;85(4):1048-1049. doi:10.1016/j.jaad.2021.02.035
Filippi F, Chessa MA, Patrizi A, Baraldi C, Ferrara F, Bardazzi F. Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica. Dermatol Pract Concept. 2019;10(1):e2020019. Published 2019 Dec 31. doi:10.5826/dpc.1001a19
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Yusuf Can Edek, Derya Yıldırım, Melike Urgancı, Betül Öğüt, Esra Adışen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.